Countable Labs achieves CE Mark Clearance for Countable 4 Platform
Countable Labs has announced the CE marking of their Countable 4 Platform, a single-molecule PCR instrument designed for high-precision molecular quantification in genomics and biopharma applications, featuring Countable PCR technology for detecting rare events with high sensitivity.
Countable Labs announced that they have achieved CE marking for their Countable 4 Platform, a single-molecule PCR instrument for molecular quantification featuring Countable PCR technology. The platform is ideal for any genomics application where rare events need to be identified and measured completely and accurately against high background samples.
Countable PCR is a highly scalable, digital PCR-like technology that features high sensitivity. Countable PCR facilitates the identification of rare events as low as 0.004% variant allele frequency (VAF), across a wide range of sample inputs. It is capable of simultaneously delivering robust sample multiplexing, dynamic range, and ease-of-use.
Countable 4 is purpose-built for biopharma and CDMO teams where accurate quantification is required. With CFR part 11 compliant software, and high sensitivity, it’s already being used to quantify genome titer and integrity as well as quantify impurities against complex AAV and genomic backgrounds, aiming to deliver the precision and audit-ready data that GMP manufacturing demands. The same platform also serves researchers working in rare variant detection and pathogen quantification.
